Carolina Schere‐Levy

435 total citations
13 papers, 367 citations indexed

About

Carolina Schere‐Levy is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Carolina Schere‐Levy has authored 13 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in Carolina Schere‐Levy's work include Cytokine Signaling Pathways and Interactions (5 papers), Reproductive System and Pregnancy (3 papers) and Renin-Angiotensin System Studies (3 papers). Carolina Schere‐Levy is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Reproductive System and Pregnancy (3 papers) and Renin-Angiotensin System Studies (3 papers). Carolina Schere‐Levy collaborates with scholars based in Argentina, United States and Japan. Carolina Schere‐Levy's co-authors include Kumiko Hosokawa, Abraham Amsterdam, Ada Dantes, Fumikazu Kotsuji, Edith C. Kordon, Israël Vlodavsky, Dorit Aharoni, Roberto P. Meiss, Amihai Barash and Yoshio Yoshida and has published in prestigious journals such as Cancer Research, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Carolina Schere‐Levy

12 papers receiving 364 citations

Peers

Carolina Schere‐Levy

ONCOL

IMMUN

PHEOH

Gabriele Leder Germany

David Maldonado‐Pérez United Kingdom

Meiyi Tang United States

Yongrui Du China

Martine Applanat France

Laura Hautala Finland

Peyda Korhan Türkiye

Weirong Shang United States

Areege Mustafa Kamal Iraq

Kengo Manase Japan

Gabriele Leder Germany

Carolina Schere‐Levy

149 ×0.9

57 ×0.4

ONCOL

65 ×0.8

IMMUN

72 ×0.8

PHEOH

67 ×1.0

Citations per year, relative to Carolina Schere‐Levy Carolina Schere‐Levy (= 1×) peers Gabriele Leder

Countries citing papers authored by Carolina Schere‐Levy

Since Specialization

Citations

This map shows the geographic impact of Carolina Schere‐Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Schere‐Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Schere‐Levy more than expected).

Fields of papers citing papers by Carolina Schere‐Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolina Schere‐Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Schere‐Levy. The network helps show where Carolina Schere‐Levy may publish in the future.

Co-authorship network of co-authors of Carolina Schere‐Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Schere‐Levy. A scholar is included among the top collaborators of Carolina Schere‐Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Schere‐Levy. Carolina Schere‐Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Schere‐Levy, Carolina, Roberto P. Meiss, Gladys N. Hermida, et al.. (2022). Aberrant RET expression affects normal mammary gland post-lactation transition, enhancing cancer potential. Disease Models & Mechanisms. 15(3). 2 indexed citations

Schere‐Levy, Carolina, et al.. (2022). Treatment with Angiotensin-(1-7) Prevents Development of Oral Papilloma Induced in K-ras Transgenic Mice. International Journal of Molecular Sciences. 23(7). 3642–3642.

Walther, Thomas, Karen Nahmod, Natalia Rubinstein, et al.. (2017). Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells. Oncotarget. 8(51). 88475–88487. 23 indexed citations

Grasso, Esteban, Pablo C. Echeverría, Luciana Rocha-Viegas, et al.. (2015). RUNX1 and FOXP3 interplay regulates expression of breast cancer related genes. Oncotarget. 7(6). 6552–6565. 34 indexed citations

Nahmod, Karen, Thomas Walther, Natalia Fernández, et al.. (2012). AT ₁ receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system. The FASEB Journal. 26(5). 1982–1994. 7 indexed citations

Quaglino, Ana, Carolina Schere‐Levy, Leonardo Romorini, Roberto P. Meiss, & Edith C. Kordon. (2007). Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling. Breast Cancer Research. 9(5). R69–R69. 20 indexed citations

Bustuoabad, Oscar D., Raúl A. Ruggiero, Maria Lombardi, et al.. (2005). Tumor Transition Zone: A Putative New Morphological and Functional Hallmark of Tumor Aggressiveness. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 15(3). 169–182. 7 indexed citations

Cirio, M. Cecilia, Ana Quaglino, Carolina Schere‐Levy, et al.. (2004). Progression of Pregnancy-Dependent Mouse Mammary Tumors after Long Dormancy Periods. Involvement of Wnt Pathway Activation. Cancer Research. 64(15). 5193–5199. 19 indexed citations

Schere‐Levy, Carolina. (2003). Leukemia Inhibitory Factor Induces Apoptosis of the Mammary Epithelial Cells and Participates in Mouse Mammary Gland Involution. Experimental Cell Research. 282(1). 35–47. 82 indexed citations

10.

Buggiano, Valeria, Carolina Schere‐Levy, Silvia I. Vanzulli, et al.. (2001). Impairment of mammary lobular development induced by expression of TGF?1 under the control of WAP promoter does not suppress tumorigenesis in MMTV-infected transgenic mice. International Journal of Cancer. 92(4). 568–576. 17 indexed citations

11.

Amsterdam, Abraham, Ada Dantes, Kumiko Hosokawa, et al.. (1998). Steroid Regulation during Apoptosis of Ovarian Follicular Cells. Steroids. 63(5-6). 314–318. 40 indexed citations

12.

Hosokawa, Kumiko, Ada Dantes, Carolina Schere‐Levy, et al.. (1998). Induction of Ad4BP/SF-1, Steroidogenic Acute Regulatory Protein, and Cytochrome P450scc Enzyme System Expression in Newly Established Human Granulosa Cell Lines¹. Endocrinology. 139(11). 4679–4687. 57 indexed citations

13.

Hosokawa, Kumiko, Dorit Aharoni, Ada Dantes, et al.. (1998). Modulation of Mdm2 Expression and p53-Induced Apoptosis in Immortalized Human Ovarian Granulosa Cells**This work was supported by grants from the Israel Academy of Sciences (to I.V. and A.A.), by the Israeli Ministry of Science (to A.A.), by the Leo and Julia Forchheimer Center of Molecular Genetics at the Weizmann Institute of Science (to A.A.) and by a Grant-in-Aid 0704424 from the Ministry of Education, Science and Culture of Japan (to F.K., K.H., and A.A.).. Endocrinology. 139(11). 4688–4700. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact